--- a
+++ b/clusters/9knumclustersv2/clust_1182.txt
@@ -0,0 +1,80 @@
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN =  U/L; for the purpose of this study, the ULN for SGOT is  U/L
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x the institutional ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase) [AST]); =<  U/L; for the purpose of this study, the ULN for SGOT is  U/L
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN (CTCAE v . grade -)
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN obtained =<  days prior to registration
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) less than or equal to . x ULN (CTCAE grade )
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =<  x ULN even in patients with documented hepatic involvement with lymphoma
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST] < . units/L)
+Serum glutamic-oxaloacetic transaminase (SGOT) aspartate aminotransferase (AST) =< . x ULN, within  days of registration
+Obtained within  days prior to registration: Serum glutamic oxaloacetic transaminase (SGOT) aspartate aminotransferase (AST) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) aspartate aminotransferase [AST] =<  x ULN =  U/L; for the purpose of this study, the ULN for SGOT is  U/L
+Serum glutamic oxaloacetic transaminase (SGOT) (AST) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) ?  x institutional ULN within  days prior to registration
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]): - U/L
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) < . x ULN
+Within  days of randomization: Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x ULN
+Within  days prior to treatment start: Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x ULN
+Aspartate aminotransferase (aspartate aminotransaminase [AST], serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) less than or equal to  x ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x ULN, or =<  x ULN in patients with documented liver metastases within  days of cycle  day 
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< . x institutional ULN
+Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT) < . x ULN
+Aspartate transaminase (AST/serum glutamic oxaloacetic transaminase [SGOT]) =< . X ULN obtained =<  days prior to registration
+Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT) =< . x ULN OR =<  x ULN for subjects with liver metastases, during screening and on cycle , day 
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =<  X institutional ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) and alkaline phosphatase less than or equal to . x ULN (CTCAE v grade )
+Aspartate aminotransferase (AST)/serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Aspartate aminotransferase (AST)/serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Aspartate aminotransferase (AST, serum glutamic-oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) < . x ULN for age
+Aspartate aminotransferase (AST) or serum glutamic oxaloacetic transaminase (SGOT) =< . x local institutional ULN
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) < . X ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Aspartate aminotransferases (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< . x institutional ULN
+Aspartate aminotransferase (AST, serum glutamic oxaloacetic transaminase [SGOT]) =<  x ULN, obtained within  days prior to registration for protocol therapy
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x ULN
+Aspartate aminotransferase (AST)/serum glutamic-oxaloacetic transaminase (SGOT) =<  x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =<  x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  U/L; for the purpose of this study, the ULN for SGOT is  U/L
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< . X ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) less than or equal to  x ULN (CTEP CTCAE version ., grade )
+If no known liver metastases: aspartate aminotransferase (AST)/serum glutamic oxaloacetic transaminase (SGOT) <  x ULN; if known liver metastases, then: AST/SGOT <  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) greater than . x ULN (CTCAE v. grade ) (if known hepatic metastases SGOT may be =<  x ULN)
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< . X institutional ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) less than or equal to  x ULN
+Aspartate aminotransaminase (AST, serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x UNL
+Obtained =<  days prior to registration: Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Aspartate aminotransferase (AST, serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN, CTCAE grade 
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< . x ULN
+Aspartate aminotransaminase (AST) (serum glutamic oxalic transaminase [SGOT]) =< . x ULN
+Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) levels =<  x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =<  x ULN
+Aspartate aminotransferase (AST) =<  x ULN (serum glutamic oxaloacetic transaminase [SGOT])
+Serum glutamic oxaloacetic transaminase (SGOT) less than or equal to . x ULN (CTCAE v. grade )
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Aspartate aminotransferase (AST, serum glutamic oxaloacetic transaminase [SGOT]) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =<  X ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferse [AST]) =<  x ULN, unless evidence of direct liver involvement by lymphoma, then =<  x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase (SGOT) less than or equal to . X ULN
+Serum glutamic oxaloacetic transaminase (SGOT) =< . x ULN
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . x ULN
+Aspartate aminotransferase (AST, serum glutamic oxaloacetic transaminase [SGOT]) =<   ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) < . x ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< .  institutional ULN
+Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< . x institutional ULN obtained =<  days prior to randomization
+Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< . ULN, obtained within  days prior to treatment start
+Serum glutamic-oxaloacetic transaminase (SGOT) and alkaline phosphatase less than or equal to . x ULN
+Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT]) =< . X ULN OR =<  x ULN for subjects with liver metastases, performed within  days of treatment initiation